NM_000350.3:c.6529G>A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000350.3(ABCA4):​c.6529G>A​(p.Asp2177Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0117 in 1,614,162 control chromosomes in the GnomAD database, including 191 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 21 hom., cov: 32)
Exomes 𝑓: 0.012 ( 170 hom. )

Consequence

ABCA4
NM_000350.3 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12O:2

Conservation

PhyloP100: 2.75
Variant links:
Genes affected
ABCA4 (HGNC:34): (ATP binding cassette subfamily A member 4) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. This protein is a retina-specific ABC transporter with N-retinylidene-PE as a substrate. It is expressed exclusively in retina photoreceptor cells, and the gene product mediates transport of an essental molecule, all-trans-retinal aldehyde (atRAL), across the photoreceptor cell membrane. Mutations in this gene are found in patients diagnosed with Stargardt disease, a form of juvenile-onset macular degeneration. Mutations in this gene are also associated with retinitis pigmentosa-19, cone-rod dystrophy type 3, early-onset severe retinal dystrophy, fundus flavimaculatus, and macular degeneration age-related 2. [provided by RefSeq, Sep 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003962189).
BP6
Variant 1-93998061-C-T is Benign according to our data. Variant chr1-93998061-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 7885.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-93998061-C-T is described in Lovd as [Likely_pathogenic]. Variant chr1-93998061-C-T is described in Lovd as [Likely_benign]. Variant chr1-93998061-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.01 (1525/152300) while in subpopulation NFE AF= 0.0123 (840/68026). AF 95% confidence interval is 0.0117. There are 21 homozygotes in gnomad4. There are 844 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 21 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCA4NM_000350.3 linkc.6529G>A p.Asp2177Asn missense_variant Exon 48 of 50 ENST00000370225.4 NP_000341.2 P78363Q6AI28
ABCA4NM_001425324.1 linkc.6307G>A p.Asp2103Asn missense_variant Exon 47 of 49 NP_001412253.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCA4ENST00000370225.4 linkc.6529G>A p.Asp2177Asn missense_variant Exon 48 of 50 1 NM_000350.3 ENSP00000359245.3 P78363

Frequencies

GnomAD3 genomes
AF:
0.0100
AC:
1525
AN:
152182
Hom.:
21
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00203
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00268
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0483
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0123
Gnomad OTH
AF:
0.00764
GnomAD3 exomes
AF:
0.0107
AC:
2692
AN:
251480
Hom.:
34
AF XY:
0.0104
AC XY:
1420
AN XY:
135914
show subpopulations
Gnomad AFR exome
AF:
0.00221
Gnomad AMR exome
AF:
0.00205
Gnomad ASJ exome
AF:
0.00704
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00189
Gnomad FIN exome
AF:
0.0480
Gnomad NFE exome
AF:
0.0118
Gnomad OTH exome
AF:
0.0124
GnomAD4 exome
AF:
0.0119
AC:
17378
AN:
1461862
Hom.:
170
Cov.:
31
AF XY:
0.0114
AC XY:
8300
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.00176
Gnomad4 AMR exome
AF:
0.00221
Gnomad4 ASJ exome
AF:
0.00643
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00206
Gnomad4 FIN exome
AF:
0.0457
Gnomad4 NFE exome
AF:
0.0124
Gnomad4 OTH exome
AF:
0.0110
GnomAD4 genome
AF:
0.0100
AC:
1525
AN:
152300
Hom.:
21
Cov.:
32
AF XY:
0.0113
AC XY:
844
AN XY:
74476
show subpopulations
Gnomad4 AFR
AF:
0.00202
Gnomad4 AMR
AF:
0.00268
Gnomad4 ASJ
AF:
0.00749
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00125
Gnomad4 FIN
AF:
0.0483
Gnomad4 NFE
AF:
0.0123
Gnomad4 OTH
AF:
0.00756
Alfa
AF:
0.00967
Hom.:
12
Bravo
AF:
0.00648
TwinsUK
AF:
0.0119
AC:
44
ALSPAC
AF:
0.0150
AC:
58
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.0124
AC:
107
ExAC
AF:
0.0102
AC:
1235
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00938
EpiControl
AF:
0.0108

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4Other:1
Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

ABCA4: BP4, BS1, BS2 -

Oct 06, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Retina International
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 26, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 17, 2017
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Retinitis Pigmentosa, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Stargardt Disease, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

ABCA4-related disorder Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Cone-Rod Dystrophy, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Macular degeneration Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

MACULAR DEGENERATION, AGE-RELATED, 2, SUSCEPTIBILITY TO Other:1
Mar 01, 1997
OMIM
Significance: risk factor
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.19
T;T
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.19
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.73
T;T
MetaRNN
Benign
0.0040
T;T
MetaSVM
Benign
-0.60
T
MutationAssessor
Benign
1.1
.;L
PrimateAI
Benign
0.33
T
PROVEAN
Benign
0.19
.;N
REVEL
Uncertain
0.31
Sift
Benign
0.27
.;T
Sift4G
Benign
0.45
T;T
Polyphen
0.061
.;B
Vest4
0.14
MPC
0.084
ClinPred
0.024
T
GERP RS
5.4
Varity_R
0.11
gMVP
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1800555; hg19: chr1-94463617; COSMIC: COSV64672891; COSMIC: COSV64672891; API